Titular de la autorización de comercialización · Estados Unidos
Hoffmann-La Roche Inc.
17 medicamentos en 1 país, como titular de la autorización.
Cargando la página…
Cargando la página…
Titular de la autorización de comercialización · Estados Unidos
17 medicamentos en 1 país, como titular de la autorización.
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos registrados a su nombre, primero los vigentes.
17 medicamentos
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| ACCUTANE10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Isotretinoin | Estados Unidos | No comercializado | 1982 |
| ALECENSA150mg base · Capsule | Alectinib | Estados Unidos | Comercializado | 2015 |
| BONIVA150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Ibandronic acid | Estados Unidos | No comercializado | 2003 |
| FORTOVASE200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Capsule | Saquinavir | Estados Unidos | No comercializado | 1997 |
| INVIRASE200mg base · Capsule | Saquinavir | Estados Unidos | No comercializado | 1995 |
| INVIRASE500mg base · Tablet | Saquinavir | Estados Unidos | No comercializado | 2004 |
| ROCEPHIN10GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1GM BASE/VIAL | 250MG BASE/VIAL | 2GM BASE/VIAL | 500MG BASE/VIAL · Injectable | Ceftriaxone | Estados Unidos | No comercializado | 1984 |
| ROCEPHIN1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 2GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons* · Injectable | Ceftriaxone | Estados Unidos | No comercializado | 1984 |
| ROCEPHIN KIT1gm base/vial,n/a; 1% | 500mg base/vial,n/a; 1% · Injectable | Ceftriaxone, N/a, Lidocaine n/a,1% | Estados Unidos | No comercializado | 1984 |
| ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 40MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Ceftriaxone | Estados Unidos | No comercializado | 1987 |
| ROMAZICON0.5MG/5ML (0.1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 1MG/10ML (0.1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Flumazenil | Estados Unidos | No comercializado | 1991 |
| ZELBORAF240mg · Tablet | Vemurafenib | Estados Unidos | Comercializado | 2011 |
| Pegasys Copegus Combination Pack180mcg/0.5ml & 1200mg | Peginterferon alfa-2b, Ribavirin | Estados Unidos | Retirado | 2004 |
| Pegasys Copegus Combination Pack180mcg/0.5ml & 800mg | Peginterferon alfa-2b, Ribavirin | Estados Unidos | Retirado | 2004 |
| Pegasys Copegus Combination Pack180mcg/0.5ml &1000mg | Peginterferon alfa-2b, Ribavirin | Estados Unidos | Retirado | 2004 |
| Roferon-A3miu/0.5ml · For Injection | Interferon alfa-2b | Estados Unidos | Retirado | 1986 |
| Zenapax25mg/5ml · Injection | Daclizumab | Estados Unidos | Retirado | 1997 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Estados Unidos | 17 | 12 | 5 | EmpresasTodos los medicamentos |
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licencia: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de Hoffmann-La Roche Inc. en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaOtras empresas del mismo grupo.
Ordenados por su número de medicamentos.